Dana Hubbard, Head of Patents for Merck Millipore, named to Boston’s Top Rated Lawyers

May 16, 2012, Darmstadt, Germany — Merck Millipore, the Life Science division of Merck KGaA, has announced that Dana Hubbard, Head of Patents,  was named to Boston’s Top Rated Lawyers. This list, created by LexisNexis Matindale-Hubbell, is a peer-reviewed rating of the leading local lawyers who have reached the highest levels of ethical standards and professional excellence. 

Who:     Dana Hubbard- Head of worldwide patents for Merck Millipore                  

What:    Recognized on Boston’s list of Top Rated Lawyers          

When:   May 2012                                            

Where:  Boston, MA                       

Why:      Dana Hubbard of Merck Millipore was recently named to Boston’s List of Top Rated Lawyers.  As head of global patents, Dana is responsible for maintaining the protection of Merck Millipore’s innovative products by staying current with patent regulations around the globe, from the US to China and Europe.

As a global life-science organization with over 40,000 products and a presence in 67 countries, leading a global Patents group requires the help of a team that spans 9 time zones. With a background in law and biology and 15 years of experience with Merck Millipore, Dana is well-equipped to handle the ever-changing and complex landscape of patents in the life science industry.

Dana says that this distinction is particularly meaningful because of the way list is put together:  “This award is decided through the input of other attorneys based on one’s professional expertise and ethical standards. It’s rewarding to be recognized by my peers as one who exhibits these qualities”.

Dana is a resident of Billerica, MA and enjoys spending his time outside of work fishing.

For more information, please contact Cait.Healey@merckgroup.com

About Merck Millipore
Merck Millipore is the Life Science division of Merck KGaA of Germany and offers a broad range of innovative, performance products, services and business relationships that enable our customers’ success in research, development and production of biotech and pharmaceutical drug therapies. Through dedicated collaboration on new scientific and engineering insights, and as one of the top three R&D investors in the Life Science Tools industry, Merck Millipore serves as a strategic partner to customers and helps advance the promise of life science.

Headquartered in Billerica, Massachusetts, the division has around 10,000 employees, operations in 67 countries and 2011 revenues of EUR 2.4 billion. Merck Millipore operates as EMD Millipore in the U.S. and Canada.

Note: Merck KGaA or Merck shall mean Merck KGaA, Darmstadt, Germany

About Merck
Merck is a global pharmaceutical and chemical company with total revenues of € 10.3 billion in 2011, a history that began in 1668, and a future shaped by more than 40,000 employees in 67 countries. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.